Best Myeloma doctors: TOP 67 doctors

• Dr. Zafer Gulbas specializes in advanced Myeloma treatment.
• Expert in stem cell transplantation, chemotherapy, and targeted therapy for Myeloma.
• Trained internationally in the USA, Canada, and Israel.
• Founded Bone Marrow Transplantation Center at Anadolu Medical Center.
• Acclaimed hematologist-oncologist with a focus on bone marrow transplant.
• Offers consultations online for patients with Myeloma.
• Fluent in English and Turkish, easing communication with diverse patients.

• Dr. Bülent Karagöz specializes in Myeloma treatment with over 20 years of experience.
• Expert in chemotherapy, stem cell transplantation, and targeted therapy for Myeloma.
• International practice in Turkey, NATO KFOR Command, and Turkish Cypriot Peace Forces.
• Member of the Turkish Medical Oncology Association, focusing on cancer therapies.
• Offers online consultations for patients with Myeloma, enhancing accessibility to his expertise.
• Converses fluently in both English and Turkish, ensuring clear communication with patients.

• Dr. Yesim Yildirim specializes in Myeloma treatment.
• Utilizes chemotherapy, stem cell transplant, and targeted therapy for Myeloma.
• Trained internationally in the U.S., Turkey, Israel, and the UK.
• Certified by the European Society of Medical Oncology (ESMO).
• Member of ESMO and the European School of Oncology (ESO).
• Offers online consultations for Myeloma patients.
• Fluent in English, Turkish, and intermediate Russian.

Professor Fabio Ciceri is the Head of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. He has over 180 papers published and has held various Medical and Teaching positions since 1989. He is a member of multiple organizations related to Hematology and was awarded a Merit Recognition Award at the University of Ferrara. He is a Principal Investigator in Cell and Gene Therapy clinical trials for haematological cancers, immune-deficiencies, and neuromuscular disorder.

Dr. Jacopo Peccatori is the Head of Bone Marrow Transplant Department in San Raffaele Scientific Institute and one of the top lymphoma doctors. He has been in this position since 2006 and has written over 70 studies on allogeneic bone marrow transplantation, acute leukemia, and multiple myeloma. He has a degree in general medicine from the University of Milan and specialties in internal medicine and haematology and is a member of The European Society for Blood and Marrow Transplantation and The Italian Group for Hematopoietic Stem Cell Transplantation and Cell Therapies.

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

• Dr. Elke Jaeger specializes in Myeloma treatment with 35+ years of experience.
• Utilizes stem cell transplantation, chemotherapy, and targeted therapy for Myeloma.
• Recognized as a top sarcoma specialist, also adept in Myeloma care.
• Head physician at a leading Oncology and Hematology Center in Germany.
• Ranked among the best German oncologists by the Focus rating.
• Provides online consultations for patients with Myeloma.
• Fluent in both German and English, ensuring clear communication.

HU KAI

Member of the Professional Committee of Geriatric Oncology, Chinese Geriatric Society.

Member of the First Chinese T-cell Lymphoma Working Group of the Professional Committee of Oncohematology of the Chinese Anti-Cancer Association.

Member of the Professional Committee on Hematopoietic Stem Cell Transplantation and Cell Therapy, Chinese Association for Medical Education.

Chairman of the Expert Committee on Accurate Diagnosis and Treatment of Blood Tumors, Beijing Health Protection Association.

Member of the Professional Committee of Hematology of Beijing Research Association.

Member of the Professional Committee of Clinical Research of Beijing Cancer Association.

Conducts in-depth research in the field of immunotherapy, biomarkers, is well acquainted with the latest international standards of diagnostics and treatment of lymphoma. Participates in 20 international and national clinical studies on diagnostics and treatment of lymphomas and multiple myeloma.

Specialization:

multidisciplinary complex treatment of hematological malignancies

early diagnosis of lymphoma, multiple myeloma, leukemia

complex standardized treatment based on drug chemotherapy, molecular targeted therapy, autologous/allogeneic hematopoietic stem cell transplantation and biological therapy

Experience

• 1990 - 1994 – General Practitioner
• 1994 - 2001 – Research Assistant, Erciyes University, Faculty of Medicine
• 2001 - 2006 – Assistant Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2006 - 2011 – Associate Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2011 - 2019 – Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine

Professional Memberships

• Turkish Society of Hematology
• European Group for Blood and Marrow Transplantation (EBMT)
• Hematologic Oncology Association
• Antalya Medical Chamber

Experience

2021 year - 2022 year

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 year - 2022 year

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 year - 2021 year

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 year - 2020 year

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 year - 2017 year

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 year - 2016 year

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 year - 2011 year

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 year - 2010 year

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006 year

Medical Faculty, Dokuz Eylül University

2006 year - 2008 year

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 year - 2006 year

Medical Faculty, Dokuz Eylül University

Education

2022 year

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022 year

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021 year

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017 year

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017 year

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006 year

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006 year

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998 year

Ege University, Faculty of Medicine

Kodchanut Litleaungdej, M.D.

• Dr. Eckhart Weidemann specializes in advanced Myeloma treatment.
• Utilizes chemotherapy, stem cell transplant, and targeted therapy for Myeloma.
• International practice in Germany and research collaborations worldwide.
• Holds vital hematology certifications, ensuring expert care.
• Member of esteemed hematology and oncology societies.
• Offers online consultations for Myeloma patients globally.
• Fluent in German and English, facilitating diverse patient communication.

Education and Expertise

• EGE UNIVERSITY FACULTY OF MEDICINE

Diseases

• Acute Leukemias
• Aplastic Anemia
• Other Hematological Cancers
• Hodgkin lymphoma
• Chronic Lymphocytes Leukemia
• Chronic myelogenous leukemia
• Multiple myeloma
• Non-Hodgkin lymphoma

Treatment Methods

• Apheresis Application
• Allogeneic Stem Cell Transplantation
• Photopheresis application
• Haploidentical
• Targeted Therapies
• Immunotherapy
• Chemoimmunotherapy
• Autologous Stem Cell Transplantation
• Plasmapheresis

Experience

• Ege University Faculty of Medicine – Department of Internal Medicine – Specialization
• Ege University Faculty of Medicine – Department of Internal Medicine – Hematology – Assistant Professorship
• Ege University Faculty of Medicine – Department of Internal Medicine – Hematology – Associate Professorship
• Ege University Faculty of Medicine – Department of Internal Medicine – Hematology – Professor

Professional Memberships

• Turkish Medical Association
•  

• Dr. Jaume Mora Graupera specializes in Myeloma treatment.
• He employs chemotherapy, stem cell transplants, and targeted therapy.
• Trained in the USA at Weill Cornell Medicine and Memorial Sloan Kettering.
• Directs Hematology Oncology Department at Sant Joan De Déu in Barcelona.
• Member of the American Society of Clinical Oncology, representing high professionalism.
• Offers remote consultations for Myeloma patients, enhancing accessibility.
• Fluent in English and Spanish, facilitating communication with diverse patients.

• Specializes in Myeloma treatment, utilizing advanced methods.
• Myeloma therapies include stem cell transplant, chemotherapy, and targeted therapy.
• International practice in countries with leading cancer research.
• Certified Hematologist, expertise in bone marrow transplantation.
• Member of professional hematological societies, ensuring up-to-date practices.
• Offers online consultations for Myeloma patients worldwide.
• Speaks multiple languages, enhancing patient comfort and understanding.

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas

Bone marrow transplantation

Prof. Dr. Şebnem İzmir Güner was born in 1970 in Istanbul and took her first steps in her medical career at Istanbul University Faculty of Medicine. Successfully completing her undergraduate and medical education here between 1987-1993, Güner received her internal medicine specialty training at Istanbul University Cerrahpaşa Faculty of Medicine from 1995 to 2000. Deepening her interest in hematology, Prof. Dr. Güner completed her hematology subspecialty training at Cerrahpaşa Faculty of Medicine again between 2003-2006, solidifying her expertise in this field.
Prof. Dr. Güner’s professional journey began as an internal medicine specialist at Istanbul Education and Research Hospital from 2000 to 2003. She established the Hematology Clinic at the same hospital from 2006 to 2010 and served as the responsible physician. Here, she developed innovative approaches in the treatment of patients and made significant contributions to the field of hematology. From 2010 to 2016, she established the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center at Medicalpark Bahçelievler Hospital and served as the responsible physician. During this period, she conducted studies that set national and international standards in the field of hematology.
Between 2016-2018, Prof. Dr. Güner took on similar roles at Şişli Kolon International Hospital, where she was also the founder and responsible physician of the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center. Güner, who became an associate professor in 2017, obtained her professorship title in 2023. Between 2019-2024, she worked at Memorial Şişli Hospital in the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center.
Prof. Dr. Şebnem İzmir Güner is recognized for her scientific contributions, with over 19 articles published in international peer-reviewed journals. Additionally, she has over 18 articles published in national peer-reviewed journals and 51 presentations at national scientific meetings that have been published in proceedings books. She has also made a name for herself in the academic world with over 18 presentations at meetings and published in proceedings books. Güner, who has held positions on the boards of domestic hematology associations and has active memberships, has crowned her success with more than three awards given at universities and conferences.
Prof. Dr. Şebnem İzmir Güner, who speaks English and German, is also recognized as an educator. In this capacity, she has contributed to the training of young doctors in the field of hematology, providing education to research assistant doctors and students.
Prof. Dr. Şebnem İzmir Güner has established a respected place in the field of hematology with her achievements and scientific contributions throughout her professional life, continuing her career as a physician who inspires her patients and colleagues.

MEDICAL INTERESTS

• Leukemia
• Lymphoma
• Multiple myeloma
• Bone marrow transplantation
• Anemia
• Bleeding and coagulation disorders
• Hemophilia